Join Us for an Exclusive ABLE Webinar!
Discover what CDSCO’s "Draft Revised Guidelines on Similar Biologics" mean for your strategy, compliance, and market opportunities in India's biotech sector".

Date: 30th May
Time: 3:30 PM – 5:00 PM IST

The session will begin with opening remarks by Dr. P. M. Murali, President of the ABLE Council of Presidents, Chairman of Golden Jubilee Biotech Park, and CMD of Jananom Pvt. Ltd. This will be followed by a keynote address from Dr. S R Rao, Founder & CEO-Genentech Regulatory Solutions LLP and Former Senior Advisor, Department of Biotechnology (DBT), Ministry of S&T, Govt.of India.

Featured speakers include:

• Mr. Prasun Guha, Vice President & Head – Biologics Regulatory Affairs, Dr. Reddy’s Laboratories Ltd.
• Dr. Charu Manaktala, Senior Director and Head – Biosimilars Center of Excellence, IQVIA

This session will dive into:

• Key updates in the revised CDSCO guidelines
• Implications for regulatory pathways
• Industry readiness and compliance strategies
• Expert perspectives on navigating the new landscape